Sliptin Tablet 25 mg contains Sitagliptin, an oral antihyperglycemic agent from the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, indicated for the management of type 2 diabetes mellitus. Sitagliptin works by enhancing the activity of incretin hormones, which regulate glucose homeostasis by increasing insulin secretion and decreasing glucagon release in a glucose-dependent manner. This action helps lower elevated blood sugar levels while minimizing the risk of hypoglycemia.

Sliptin 25 mg is commonly prescribed for adults with type 2 diabetes who cannot achieve adequate glycemic control with diet and exercise alone. It can be used as monotherapy or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin to improve overall glycemic control. The 25 mg dose is typically a starting or low-dose option, suitable for patients requiring gradual adjustment or those with renal impairment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Sitagliptin 25 mg per tablet

Mechanism of Action

Sliptin Tablet 25 mg works by selectively inhibiting the Dipeptidyl Peptidase-4 (DPP-4) enzyme:

• DPP-4 breaks down incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)

• By inhibiting DPP-4, Sliptin prolongs the action of incretins, which:

  • Stimulate insulin secretion from pancreatic beta cells after meals

  • Suppress glucagon release from pancreatic alpha cells, reducing hepatic glucose output

• Effects occur only when blood glucose is elevated, helping control hyperglycemia with a low risk of hypoglycemia

• Improves both fasting and postprandial blood glucose levels

Indications

Sliptin Tablet 25 mg is indicated for:

• Type 2 diabetes mellitus in adults with inadequate glycemic control from diet and exercise

• Combination therapy with other antidiabetic agents like metformin, sulfonylureas, or insulin for improved glycemic management

• Patients seeking a convenient once-daily oral therapy with a low risk of hypoglycemia

• Suitable for long-term management of type 2 diabetes as part of a comprehensive care plan

Dosage and Administration

• The recommended dose is 25 mg once daily, taken orally, with or without food.

• Swallow the tablet whole with water; do not crush or chew.

• Maintain consistent daily administration for optimal blood glucose control.

• Dose adjustments may be necessary in patients with renal impairment; consult a healthcare provider before use.

• Can be used as monotherapy or in combination therapy depending on individual needs.

Benefits

• Effectively lowers fasting and postprandial blood glucose levels

• Glucose-dependent mechanism reduces the risk of hypoglycemia

• Convenient once-daily oral dosing enhances patient adherence

• Can be safely combined with other antidiabetic medications

• Supports long-term metabolic health and helps reduce diabetes-related complications

Precautions

• Not indicated for type 1 diabetes or diabetic ketoacidosis

• Monitor renal function in patients with kidney impairment

• Maintain diet and exercise programs alongside therapy

• Use with caution during pregnancy and lactation; consult a physician

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects:

• Headache

• Nasopharyngitis

• Mild gastrointestinal discomfort, such as nausea or diarrhea

Rare but serious side effects:

• Pancreatitis (persistent abdominal pain, possibly radiating to the back)

• Hypersensitivity reactions, including rash, swelling, or hives

• Severe joint pain or heart failure exacerbation in predisposed patients

Storage

Store in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep out of reach of children.

Sliptin Tablet 25 mg is an effective, safe, and convenient option for managing type 2 diabetes, improving glycemic control, enhancing insulin response, and supporting long-term metabolic health with minimal hypoglycemia risk.